FOXA1 and cancer: Consistent with this, FOXA1 mutations and transcriptional activities had no significant effect on overall survival in pan-cancer level (Figures 5A,C), and FOXA1 mutations only led to a worse prognosis in BRCA (p = 0.044, Figure 5B).